http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Multidisciplinary perspectives on newly revised 2018 FIGO staging of cancer of the cervix uteri
Jonathan S. Berek,Koji Matsuo,Brendan H. Grubbs,David K. Gaffney,Susanna I. Lee,Aoife Kilcoyne,천기정,유종우,Lu Liu,Yifeng Shao,Tianhui Chen,김미선,Mikio Mikami 대한부인종양학회 2019 Journal of Gynecologic Oncology Vol.30 No.2
Recent developments in imaging technology, radiotherapeutic approaches, biological target therapy, and increased use of minimally invasive surgery have drastically changed the paradigm for management of women with cervical cancer. Until now, the International Federation of Gynecology and Obstetrics (FIGO) staging system was based primarily on clinical examination with limited additional diagnostic procedures allowed by the FIGO staging system. In 2018, the prior 2014 FIGO staging system was revised to incorporate imaging and pathological findings, when available, into the new staging system (Table 1) [1]. Multidisciplinary perspectives on newly revised 2018 FIGO staging of cancer of the cervix uteri are discussed by gynecologic oncologists, radiation oncologists, radiologists, pathologists, and epidemiologists in this manuscript (Table 2).